Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

New England Journal of Medicine,Volume 387, Issue 24, Page 2211-2219, December 2022.
Source: New England Journal of Medicine - Category: Internal Medicine Authors: Source Type: research